1. Service Overview & Global Regulatory Compliance Framework
Our biopharmaceutical Commissioning and Qualification (C&Q) services deliver systematic, audit-verified technical validation solutions fully compliant with FDA cGMP, EMA Annex 1, PIC/S harmonized GMP and ICH Q8/Q9/Q10 quality risk management and data integrity guidelines. Covering full-lifecycle commissioning, equipment calibration, system performance verification and formal qualification documentation, our service scope encompasses new facility startup, brownfield renovation validation, process system upgrade verification and legacy equipment requalification for monoclonal antibodies, recombinant proteins, viral vectors and vaccine manufacturing. Traditional project handover commonly presents industry pain points including decoupled commissioning and qualification workflows, incomplete system performance verification, disorganized validation records, insufficient risk-based judgment and audit-deficient technical dossiers. Adopting standardized global C&Q governance mechanisms, we implement traceable, risk-classified validation execution, eliminating compliance loopholes and delivering fully inspection-ready system qualification outcomes for global biotech enterprises, CMO manufacturing platforms and international biopharmaceutical EPC projects.
2. Core Service Philosophy & Risk-Based C&Q Advantages
Guided by quality-by-design and risk-based graded qualification, our C&Q system prioritizes intrinsic system compliance, operational reproducibility and continuous inspection readiness rather than conventional document-oriented passive filing. We classify critical systems and impact factors based on product critical quality attributes (CQAs) and critical process parameters (CPPs), implementing targeted commissioning verification and hierarchical qualification control. All field testing, parameter calibration and data recording strictly comply with ASME BPE sanitary requirements and ALCOA+ data integrity principles, ensuring full traceability, accuracy and irreversibility of validation data. Different from fragmented document-only qualification services, our integrated C&Q model combines on-site functional commissioning, performance benchmark verification and systematic risk assessment, effectively avoiding unqualified system startup, reducing post-operation deviation risks and sustaining long-term cross-jurisdiction GMP audit compliance for biomanufacturing facilities and utility systems.
3. Four Core C&Q Modules & Standard Deliverables
Our complete biopharmaceutical C&Q service system consists of four interlocked full-process functional modules covering testing, verification, qualification and documentation: systematic commissioning & function testing module, Installation Qualification (IQ) verification module, Operational Qualification (OQ) calibration module, and Performance Qualification (PQ) validation & documentation module. The commissioning module conducts mechanical functional testing, utility system linkage debugging, sanitary performance inspection and pre-qualification risk assessment to confirm system construction integrity and operational feasibility. The IQ module verifies equipment installation specifications, material certification, pipeline configuration and document consistency, ensuring full compliance with design URS and engineering standards. The OQ module calibrates critical operating parameter windows, simulates full-load operational scenarios and verifies system stability under standard production conditions. The PQ module performs continuous batch performance verification, process consistency validation and long-term operational stability assessment. Standard deliverables include full commissioning test reports, IQ/OQ/PQ validation packages, risk assessment files, calibration certificates and audit-ready English-version compliance dossiers.
4. Industrial Application & Full Lifecycle Validation Support
Our professional C&Q services are widely applicable in greenfield biomanufacturing plant commissioning, brownfield GMP retrofitting qualification, clinical pilot platform validation, commercial production system requalification and multi-product flexible CMO facility compliance confirmation. All C&Q execution frameworks adopt modular and risk-upgradable logic, supporting adaptive validation for process intensification upgrading, equipment iteration and new product pipeline switching. We provide full-lifecycle validation support including pre-commissioning scheme formulation, on-site technical guidance, abnormal deviation troubleshooting, periodic requalification management and pre-audit document rectification. Through standardized risk-based C&Q implementation, we help global biopharmaceutical clients achieve fast and compliant project handover, stabilize system operational performance, shorten facility inspection readiness cycles, and accelerate regulatory registration and sustainable commercial production of innovative biotherapeutic products.
